Olga Danilchanka works as a Partner, MRL Ventures Fund at Merck. The firm's known portfolio counts 27 companies.
Is Olga Danilchanka a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHealthcare
Contacts
Affiliated funds' portfolios
Partner, MRL Ventures Fund at Merck, whose known portfolio counts 27 companies
- Mosaic
- Octave
- Artios Pharma
- Unnatural Products
- Formo
- Ambrosia Biosciences
- Atropos Health
- PreciseDx
- Moderna
- Aktis Oncology
- Orna Therapeutics
- Variational AI
- and 15 more
Investor Profile
The listing covers sectors AI and Healthcare, and focus areas AI Applications, Biotech, Diagnostics and Drug Discovery. Startups operating in these areas may find Olga Danilchanka relevant.
Merck appears in Growth, Late-Stage and Seed rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Olga Danilchanka matches their raise.
Colleagues at Merck
Joe Volpe
Managing Director
Hatfield, United States
Peter Dudek
President & Managing Partner, MRL Ventures Fund
Cambridge, United States
Tao Fang
Investor
Boston, United States
Harry Arader
President
St Louis, United States
Neil Strotman
Director, Oral Formulations Science
Metuchen, United States
William Taranto
President
New Hope, United States
Tony Martinez
Investor
Lambertville, United States
Sammie Irwin
Investor
O'Fallon, United States
Pan Fsa
Venture Capital & Private Equity Professional
India
Frequently asked questions
Who is Olga Danilchanka?
Olga Danilchanka is a corporate venture investor based in Cambridge, Massachusetts, United States, listed as Partner, MRL Ventures Fund at Merck. The known portfolio of that firm counts 27 companies. That portfolio belongs to the firm, not to Olga Danilchanka personally.
What does Olga Danilchanka invest in?
Listed sectors include AI and Healthcare; listed focus areas include AI Applications, Biotech, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Olga Danilchanka invest at?
Merck appears in Growth, Late-Stage and Seed rounds across its known deals, and Olga Danilchanka is listed there as Partner, MRL Ventures Fund. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Olga Danilchanka listed at?
Olga Danilchanka is listed as Partner, MRL Ventures Fund at Merck. 9 other people in the database share a firm with Olga Danilchanka.
How do I contact Olga Danilchanka?
An email address, a phone number and a LinkedIn page are on file for Olga Danilchanka. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal